Dicloxacillin absorption and elimination in children

Area of Science:

• Pharmacology
• Pediatric Pharmacokinetics
• Drug Absorption

Background:

• Dicloxacillin is a crucial antibiotic for treating bacterial infections.
• Understanding its pharmacokinetic profile in pediatric populations is essential for effective dosing.
• Age-related differences in drug metabolism and absorption can significantly impact therapeutic outcomes.

Purpose of the Study:

• To determine the apparent bioavailability of dicloxacillin in children across a wide age range.
• To investigate age-dependent variations in dicloxacillin absorption and elimination.
• To assess the impact of age on the variability of dicloxacillin bioavailability.

Main Methods:

• A pharmacokinetic study comparing intravenous and oral administration of dicloxacillin (25 mg/kg) in 26 children.
• Measurement of serum drug concentrations over time to calculate the area under the curve (AUC).
• Analysis of key pharmacokinetic parameters including half-life, volume of distribution, time to peak concentration, and bioavailability.

Main Results:

• The overall mean oral bioavailability of dicloxacillin was 59.89%.
• Children under 6 months exhibited lower oral bioavailability (64.35%) and shorter time to peak concentration compared to older children.
• Older children (over 60 months) showed higher oral bioavailability (79.38%) but greater variability (CV 32.87%) in absorption.

Conclusions:

• Dicloxacillin bioavailability in children is significantly influenced by age, with notable differences observed in younger and older pediatric groups.
• While younger children (<6 months) have less variable absorption, older children (>60 months) demonstrate higher bioavailability, suggesting age-specific dosing considerations.
• The formulation did not appear to influence the observed variability in dicloxacillin absorption across different age groups.